Neuroscience

Challenges remain in HIV care in Africa

Barriers to diagnosis and lack of access to modern medications have combined to place caregivers and HIV-positive patients in sub-Saharan Africa between a rock and a hard place. A new study shows that physicians are often ...

Genetics

CRISPR screening identifies potential HIV treatment targets

Investigators from Whitehead Institute, the Ragon Institute of MGH, MIT and Harvard and the Broad Institute of MIT and Harvard have used CRISPR-Cas9 gene-editing technology to identify three promising new targets for treatment ...

HIV & AIDS

For one Egyptian with HIV, the stigma is too much to bear

In his bedroom, there's a drawer full of his medications—along with CDs of a popular Egyptian Muslim preacher. On the walls of the home are two paintings by his father. They've had a strained relationship. He opens an album ...

HIV & AIDS

IPM's ring study results published

The International Partnership for Microbicides (IPM) announced today that The New England Journal of Medicine (NEJM) has published results from The Ring Study, a Phase III clinical trial of IPM's vaginal ring to prevent HIV. ...

HIV & AIDS

S.Africa launches major new trial of AIDS vaccine

South Africa on Wednesday launched a major clinical trial of an experimental vaccine against the AIDS virus, which scientists hope could be the "final nail in the coffin" for the disease.

page 39 from 40